767P Retrospective analysis of the impact of bevacizumab dose-intensity on the survival of platinum-resistant ovarian cancer patients

Authors :: J.A. Bahena
L. Cetina-Pérez
D. Gallardo-Rincón
P. Cabrera-Galeana
G.C. Alamilla Garcia
E. Montes-Servín
E. Varela-Santoyo
Source :: Annals of Oncology. 32:S750-S751
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
Bevacizumab
business.industry
Hematology
medicine.disease
Dose intensity
Internal medicine
medicine
Retrospective analysis
business
Ovarian cancer
Platinum resistant
medicine.drug

Full Text Access

Tools